Point: Cesium-131: Ready for Prime Time
Authors: Bice WS
- Home
- About
- Brachytherapy
Patient Information
Clinician Information
Cesium 131 Products
- Theranostics
- Newsroom
- Investor Center
- Contact us
Early Outcomes of Prostate Seed Implants with 131Cs: Toxicity and Initial PSA Dynamics from a Single Institution
Authors
C.S. Platta, D. Khuntia, J. Adkinson, E. Olson, S. Jennifer, H. Odau, R.R. Patel
- Published in journal:
International Journal of Radiation Oncology Biology Physics
September 1, 2008
Dr. Platta from the University of Wisconsin describes the outcomes of 67 patients treated with Cesium-131 prostate brachytherapy. He reports that the rate of PSA decline following treatment with Cesium-131 may be faster than for other brachytherapy radioisotopes. Because of the quick resolution of urinary side effects, Dr. Platta and his colleagues call for larger scale studies into Cesium-131 prostate brachytherapy.
Related posts
Dosimetric Comparison of Cesium-131 and Palladium-103 for Permanent Prostate Brachytherapy
Authors: J.S. Musmacher, R.T. Byrnes, M. Ghaly, K. Satchwill, L. Rumpf
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
Authors: Amar U. Kishan, MD; Ryan R. Cook, MSPH; Jay P. Ciezki, MD; et al
Long-Term Quality of Life in Prostate Cancer Patients Treated With Cesium-131
Authors: Glaser SM, Chen KS, Benoit RM, Smith RP, Beriwal S.
Company
Brachytherapy
Theranostics
Company
©2023. All rights reserved. Terms & Privacy | Privacy Policy